-

08:48:30 PM

MRNA Stock News

MRNA - Moderna Inc

11/29/22 8:00 AM

Nasdaq : MRNA

conferences

Moderna to Present at the Piper Sandler 34th Annual Healthcare Conference

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Thursday, Dec. 1 st at 9:00

RHEA-AI

neutral

11/17/22 8:10 AM

Nasdaq : MRNA

David Jiménez Joins Moderna As U.S. General Manager

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the appointment of David Jiménez as General Manager, United States, effective November 21, 2022. Mr. Jiménez will be

RHEA-AI

neutral

11/16/22 4:30 PM

Nasdaq : MRNA

Moderna Tops BioSpace's Best Places to Work Ranking for Second Consecutive Year

Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it was ranked the number one large employer in BioSpace's 2023 Best Places to Work in Biopharma report. "We are honored to

RHEA-AI

very positive

11/14/22 7:00 AM

Nasdaq : MRNA

clinical trial

Moderna's BA.4/BA.5 Targeting Bivalent Booster, mRNA-1273.222, Meets Primary Endpoint of Superiority Against Omicron Variants Compared to Booster Dose of mRNA-1273 in Phase 2/3 Clinical Trial

In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273 Results build upon data recently published in the New England Journal of Medicine that confirmed superiority of the Company's

RHEA-AI

neutral

11/10/22 7:35 AM

Nasdaq : MRNA

Moderna Shares Environmental, Social and Governance Highlights at First ESG Day

Moderna continues development of at least 15 vaccine programs targeting emerging or neglected infectious diseases by 2025 as part of global health program Moderna is committed to clinical trial diversity to ensure health equity Moderna working to achieve net-zero carbon emissions globally by 2030

RHEA-AI

positive

11/09/22 8:00 AM

Nasdaq : MRNA

conferences

Moderna to Present at the Jefferies 2022 London Healthcare Conference

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a fireside chat at the Jefferies 2022 London Healthcare Conference on Wednesday, Nov. 16 th at 8:30

RHEA-AI

neutral

11/04/22 5:00 PM

Nasdaq : MRNA

Moderna Receives Health Canada Authorization for Second Omicron-Targeting Bivalent Booster

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA)

RHEA-AI

neutral

11/03/22 7:00 AM

Nasdaq : MRNA

earnings

Moderna Reports Third Quarter 2022 Financial Results and Provides Business Updates

Third quarter 2022 revenues of $3.4 billion; GAAP net income of $1.0 billion and GAAP diluted EPS of $2.53 Revenue from advance purchase agreements for anticipated delivery in 2022 expected to be $18 to $19 billion, following delay of certain deliveries into 2023 due to short-term supply

RHEA-AI

neutral

11/01/22 1:30 AM

Nasdaq : MRNA

covid-19

Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222

Moderna, Inc . (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change to a

RHEA-AI

neutral

10/27/22 4:05 PM

Nasdaq : MRNA

conferences

Moderna to Host First Environmental, Social and Governance (ESG) Day on November 10, 2022

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host its first virtual ESG Day for analysts and investors at 9:00 a.m. ET on Thursday, November 10. Moderna's

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next